Verminderte Knochendichte und Veränderungen im ...

Literaturverzeichnis
143. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The
pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998;128:127-
37.
144. Pariante CM, Orru MG, Baita A, Farci MG, Carpiniello B. Treatment with
interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders. Lancet.
1999;354:131-2.
145. Passariello R, Albanese CV, Kvasnov, agrave. Bone densitometry in the clinical
practice. Eur Radiol. 1997;7:2-10.
146. Passeri G, Girasole G, Jilka RL, Manolagas SC. Increased interleukin-6
production by murine bone marrow and bone cells after estrogen withdrawal.
Endocrinology. 1993;133:822-8.
147. Pavol MA, Meyers CA, Rexer JL, Valentine AD, Mattis PJ, Talpaz M. Pattern of
neurobehavioral deficits associated with interferon alfa therapy for leukemia. Neurology.
1995;45:947-50.
148. Petronijevic M, Petronijevic N, Ivkovic M, et al. Low bone mineral density and
high bone metabolism turnover in premenopausal women with unipolar depression. Bone.
2008;42:582-90.
149. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory
cytokine activity after menopause. Endocr Rev. 2002;23:90-119.
150. Plata-Salaman C, Turrin N. Cytokine interactions and cytokine balance in the
brain: relevance to neurology and psychiatry. Mol Psychiatry. 1999;4:302-6.
151. Pogoda P, Priemel M, Rueger JM, Amling M. Bone remodeling: new aspects of
a key process that controls skeletal maintenance and repair. Osteoporos Int. 2004.
152. Poli V, Balena R, Fattori E, et al. Interleukin-6 deficient mice are protected from
bone loss caused by estrogen depletion. Embo J. 1994;13:1189-96.
153. Prestwood KM, Kenny AM, Kleppinger A, Kulldorff M. Ultralow-dose
micronized 17beta-estradiol and bone density and bone metabolism in older women: a
randomized controlled trial. Jama. 2003;290:1042-8.
73